IQVIA Holdings Inc. earnings per share and revenue
On Oct 28, 2025, IQV reported earnings of 3.00 USD per share (EPS) for Q3 25, missing the estimate of 3.00 USD, resulting in a -0.04% surprise. Revenue reached 4.10 billion, compared to an expected 4.12 billion, with a -0.40% difference. The market reacted with a +0.32% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 22 analysts forecast an EPS of 3.42 USD, with revenue projected to reach 4.28 billion USD, implying an increase of 14.00% EPS, and increase of 4.49% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
AngioDynamics, Inc.
Report Date
Jan 06, 2026 For Q2 26
Estimate
-$0.10
Actual
$0.00
Surprise
+100.00%
FAQ
What were IQVIA Holdings Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, IQVIA Holdings Inc. reported EPS of $3.00, missing estimates by -0.04%, and revenue of $4.10B, -0.4% below expectations.
How did the market react to IQVIA Holdings Inc.'s Q3 2025 earnings?
The stock price moved up 0.32%, changed from $217.43 before the earnings release to $218.13 the day after.
When is IQVIA Holdings Inc. expected to report next?
The next earning report is scheduled for Feb 04, 2026.
What are the forecasts for IQVIA Holdings Inc.'s next earnings report?
Based on 22
analysts, IQVIA Holdings Inc. is expected to report EPS of $3.42 and revenue of $4.28B for Q4 2025.